Abstract:Taurine, considered a non‐essential amino acid that differs from other amino acids in that it contains a sulfonic acid instead of a carboxyl group, is the most abundant amino acid in the retina. Taurine plays a critical role in maintaining retinal health and the survival of retinal neurons, although its exact function in the retina is not yet fully understood. Interestingly, taurine shares structural similarities with β‐alanine, another non‐proteinogenic amino acid that can act as a competitive inhibitor of taurine receptors, allowing β‐alanine to be used to induce taurine depletion. β‐alanine induced taurine depletion results in the activation and migration of microglial cells in the retina, oxidative stress in the inner and outer nuclear and ganglion cell layers, loss of retinal synaptic connectivity, and impaired phagocytic capacity of retinal pigment epithelial cells. In addition, taurine depletion leads to photoreceptor and retinal ganglion cell loss. Most of these detrimental events are exacerbated by light exposure. These findings suggest that taurine levels are associated with retinal sensitivity to light. Given the important role of taurine in the retina, it has been proposed as a promising therapeutic candidate for retinal degenerative diseases. These diseases, which can be inherited or acquired, are a leading cause of irreversible blindness worldwide. Age‐related macular degeneration is the most common acquired cause of photoreceptor degeneration and a major public health concern due to the aging population. Retinitis pigmentosa is the most common inherited retinal degenerative disease, which is a heterogeneous group of sight‐threatening disorders. These diseases share photoreceptor degeneration as a common feature, typically due to genetic defects affecting the photoreceptors or the retinal pigment epithelium but can also be influenced by environmental factors. Additionally, inflammation and oxidative stress contribute to their development and progression. These diseases represent a major economic burden to healthcare systems and society. Therefore, it is imperative to develop preventive and/or therapeutic strategies that can impede or halt their progression. Taurine supplementation is a promising therapeutic approach for these diseases due to its antioxidant, anti‐apoptotic, and anti‐inflammatory properties. Our group has investigated the effects of taurine supplementation in the Royal College of Surgeons (RCS) rat, an established model of inherited retinal degeneration that manifests an impaired phagocytic capacity of the retinal pigment epithelium due to a MERKT gene mutation. Our findings demonstrate that taurine supplementation improves functional photoreceptor survival, decreases glial activation (including decreased GFAP expression in Müller cells and inhibition of microglial activation and migration), reduces oxidative stress in the outer and inner nuclear layers, suppresses apoptosis, and preserves synaptic connections in the RCS rat retina. Therefore, taurine is essential for retinal health and may provide neuroprotection against retinal degeneration thanks to its multifaceted properties.

Role of Taurine Transporter in the Retinal Uptake of Vigabatrin

Taurine deficiency is a cause of vigabatrin-induced retinal phototoxicity.

Taurine deficiency damages photoreceptors and retinal ganglion cells in vigabatrin-treated neonatal rats

RP-HPLC method for simultaneous estimation of vigabatrin, gamma-aminobutyric acid and taurine in biological samples

Taurine is a crucial factor to preserve retinal ganglion cell survival

On the potential therapeutic role of taurine in retinal degenerative diseases

Treatment of Epilepsy: the Gaba-Transaminase Inhibitor, Vigabatrin, Induces Neuronal Plasticity in the Mouse Retina

Taurine provides neuroprotection against retinal ganglion cell degeneration

Reciprocal regulation between taurine and glutamate response via Ca2+-dependent pathways in retinal third-order neurons

Inhibition of Uptake, Steady‐state Currents, and Transient Charge Movements Generated by the Neuronal GABA Transporter by Various Anticonvulsant Drugs

Characterization of taurine transport in human glioma GL15 cell line: Regulation by protein kinase C

Taurine Protects Retinal Cells and Improves Synaptic Connections in Early Diabetic Rats.

Vigabatrin-associated brain abnormalities on MRI in tuberous sclerosis complex patients with infantile spasms: are they preventable?

Taurine Buffers Glutamate Homeostasis in Retinal Cells in Vitro under Hypoxic Conditions.

GABA Transaminase Inhibition Induces Spontaneous and Enhances Depolarization-Evoked GABA Efflux Via Reversal of the GABA Transporter

The absorptive flux of the anti-epileptic drug substance vigabatrin is carrier-mediated across Caco-2 cell monolayers

Vigabatrin Induces Tonic Inhibition Via Gaba Transporter Reversal Without Increasing Vesicular Gaba Release

Effects of Intracellular Zinc Chelator In Vivo on Taurine Transport,Taurine Concentrations and Taurine Transporter in Rat Retina Cells

Effect of GABAB receptors on taurine-regulate release of amino acids from rat cortical synaptosomes

Taurine Protects Against Bilirubin-Induced Hyperexcitation in Rat Anteroventral Cochlear Nucleus Neurons.

Taurine-Induced Modulation Of Voltage-Sensitive Na+ Channels In Rat Dorsal Root Ganglion Neurons